• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
VYNT

VYNT

Vyant Bio, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.19

+0.01 (+7.78%)

Company Profile

CEO

Andrew D.C. LaFrence CPA

IPO Date

2021-04-01

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.18

Prev. Close

$0.18

Day Low

$0.17

Day High

$0.20

52W Low

$0.14

52W High

$1.58

Volume

0.02M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

7

Avg Positive

36.6%

Avg Negative

13.3%

Avg Neutral

50.3%

News Feed

Vyant Bio Announces Issuance of Key Patent for High-Throughput Optical Assay of Human Mixed Cell Population Spheroids

GlobeNewsWire·7/13/2021·↑ positive

Vyant Bio (VYNT) Stock: Over 8% Increase Pre-Market Explanation

Pulse2·5/18/2021·↑ positive

Vyant Bio Reports First Quarter 2021 Results and Provides Strategic Business Update

GlobeNewsWire·
5/17/2021
·↑ positive

Vyant Bio to Present at BioNJ's 11th Annual BioPartnering Conference

GlobeNewsWire·5/11/2021·↑ positive

3 Short Squeeze Candidates In The Health Care Sector

Benzinga·5/6/2021·↓ negative

Vyant Bio, Inc., Ordaōs Bio, and Cellaria, Inc. Announce Collaboration to Design and Qualify Biomarker-Specific Small Protein Therapeutics

GlobeNewsWire·4/22/2021·↑ positive

Vyant Bio Announces Newly Appointed Board of Directors

GlobeNewsWire·4/5/2021·↑ positive